首页 正文

Engineered HSP90-MP65 Bivalent Fusion Antigen: A Novel Vaccine Candidate Against Invasive Candidiasis

{{output}}
Invasive candidiasis represents a critical global health challenge, causing approximately 6.5 million bloodstream infections annually with mortality rates exceeding 60%. The emergence of multidrug-resistant Candida strains necessitates novel prophylactic strat... ...